Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela X Nan

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Molecular Therapy. Methods & Clinical Development|June 16, 2025
Development of circular AAV cargos for targeted seamless insertion with large serine integrasesBrett J G Estes, Nisha Gandhi, Jessica R Von Stetina, et al.
American Journal of Human Genetics|April 2, 2026
Implications of the FDA's new plausible mechanism framework for the development of a personalized in vivo prime editing platformEmily R Feierman, Madelynn N Whittaker, Aidan Quigley, et al.
Nature Communications|December 10, 2025
Ligase-mediated programmable genomic integration (L-PGI)Angela X Nan, Michael Chickering, Christopher L Bartolome, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Molecular Therapy. Methods & Clinical Development|June 16, 2025
Development of circular AAV cargos for targeted seamless insertion with large serine integrasesBrett J G Estes, Nisha Gandhi, Jessica R Von Stetina, et al.
American Journal of Human Genetics|April 2, 2026
Implications of the FDA's new plausible mechanism framework for the development of a personalized in vivo prime editing platformEmily R Feierman, Madelynn N Whittaker, Aidan Quigley, et al.
Nature Communications|December 10, 2025
Ligase-mediated programmable genomic integration (L-PGI)Angela X Nan, Michael Chickering, Christopher L Bartolome, et al.
Pageof 1